News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
835,972 Results
Type
Article (85828)
Company Profile (756)
Press Release (749388)
Section
Business (232359)
Career Advice (4115)
Deals (39674)
Drug Delivery (122)
Drug Development (90762)
Employer Resources (194)
FDA (18008)
Job Trends (17284)
News (395804)
Policy (39639)
Tag
Academia (2975)
Alliances (56628)
Alzheimer's disease (1391)
Approvals (17938)
Artificial intelligence (197)
Bankruptcy (396)
Best Places to Work (12591)
Biotechnology (519)
Breast cancer (216)
Cancer (1599)
Cardiovascular disease (138)
Career advice (3519)
Cell therapy (350)
Clinical research (72223)
Collaboration (598)
Compensation (312)
COVID-19 (2819)
C-suite (140)
Data (1494)
Diabetes (207)
Diagnostics (6732)
Earnings (94947)
Employer resources (167)
Events (127732)
Executive appointments (486)
FDA (18802)
Funding (536)
Gene therapy (245)
GLP-1 (741)
Government (5059)
Healthcare (20795)
Infectious disease (2925)
Inflammatory bowel disease (127)
Interviews (808)
IPO (17676)
Job creations (5180)
Job search strategy (2856)
Layoffs (502)
Legal (10058)
Lung cancer (241)
Manufacturing (246)
Medical device (14474)
Medtech (14479)
Mergers & acquisitions (22214)
Metabolic disorders (569)
Neuroscience (1785)
NextGen: Class of 2025 (7670)
Non-profit (5073)
Northern California (1896)
Obesity (323)
Opinion (252)
Patents (140)
People (64527)
Pharmaceutical (153)
Phase I (22267)
Phase II (31361)
Phase III (23628)
Pipeline (626)
Postmarket research (3550)
Preclinical (10020)
Radiopharmaceuticals (261)
Rare diseases (312)
Real estate (7376)
Regulatory (26219)
Research institute (2645)
Resumes & cover letters (649)
Southern California (1646)
Startups (4280)
United States (17661)
Vaccines (677)
Weight loss (250)
Date
Today (206)
Last 7 days (994)
Last 30 days (2359)
Last 365 days (37984)
2025 (1449)
2024 (38191)
2023 (42569)
2022 (53928)
2021 (58724)
2020 (57670)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Arizona (238)
Asia (49606)
Australia (8738)
California (4412)
Canada (1556)
China (372)
Colorado (201)
Connecticut (224)
Europe (113598)
Florida (605)
Georgia (152)
Illinois (494)
Indiana (259)
Maryland (735)
Massachusetts (3520)
Michigan (204)
Minnesota (339)
New Jersey (1234)
New York (1233)
North Carolina (925)
Northern California (1896)
Ohio (161)
Pennsylvania (1017)
South America (1649)
Southern California (1646)
Texas (650)
Utah (126)
Washington State (469)
There are 835,972 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Verastem Oncology Exercises Option Early to License VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, from GenFleet Therapeutics and Provides Preliminary Clinical Update on Phase 1 Study in China
January 14, 2025
·
11 min read
Press Releases
World’s First Drug Candidate developed by Organoid and AI Doses First Patient in Phase 1 Study for first Diffusive Gastric Cancer Targeted Therapy
January 14, 2025
·
3 min read
Press Releases
Olfactive Biosolutions Granted Third Dual GLP-1 / GIP Patent to Repurpose Food Molecules for Weight Management and Blood Sugar Regulation
January 14, 2025
·
2 min read
Press Releases
Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenue
January 14, 2025
·
7 min read
Press Releases
Vericel Announces Preliminary 2024 Financial Results, 2025 Financial Guidance and Increased Mid-Term Profitability Targets
January 14, 2025
·
10 min read
Press Releases
Context Therapeutics Announces First Patient Dosed in the Phase 1 Clinical Trial of CTIM-76
January 14, 2025
·
4 min read
Press Releases
Serina Therapeutics Welcomes Karen J. Wilson to its Board of Directors
January 14, 2025
·
5 min read
Press Releases
Glaukos Announces Positive Clinical Updates for its iDose® Sustained-Release Procedural Pharmaceutical Platform
January 14, 2025
·
7 min read
Earnings
Lilly Projects 2024 Revenue Miss as Zepbound, Mounjaro Disappoint
The updated guidance, which was largely driven by lower-than-anticipated sales of GLP-1 blockbusters Mounjaro and Zepbound, sent Eli Lilly’s shares cratering by as much as 8% Tuesday, even as the company forecasted robust 2025 revenue.
January 14, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
icotec Announces FDA clearance for Spinal Infection Indication with BlackArmor® Implants
January 14, 2025
·
3 min read
1 of 83,598
Next
